Literature DB >> 26481572

Response to Letters Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".

Selma F Mohammed1, Margaret M Redfield1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26481572      PMCID： PMC4653071          DOI： 10.1161/CIRCULATIONAHA.115.017050

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Differences in myocardial structure and coronary microvasculature between men and women with coronary artery disease.

Authors:  Duncan J Campbell; Jithendra B Somaratne; Alicia J Jenkins; David L Prior; Michael Yii; James F Kenny; Andrew E Newcomb; Darren J Kelly; Mary Jane Black
Journal:  Hypertension       Date:  2010-12-06       Impact factor: 10.190

2.  Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.

Authors:  Selma F Mohammed; Saad Hussain; Sultan A Mirzoyev; William D Edwards; Joseph J Maleszewski; Margaret M Redfield
Journal:  Circulation       Date:  2014-12-31       Impact factor: 29.690

3.  Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Barry A Borlaug; Véronique L Roger; Sultan A Mirzoyev; Richard J Rodeheffer; Julio A Chirinos; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2012-10-17       Impact factor: 8.790

4.  Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy?

Authors:  Nicola C Edwards; Asle Hirth; Charles J Ferro; John N Townend; Richard P Steeds
Journal:  J Am Soc Echocardiogr       Date:  2008-12       Impact factor: 5.251

5.  Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy.

Authors:  K Rakusan; M F Flanagan; T Geva; J Southern; R Van Praagh
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

6.  Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.

Authors:  Panagiotis Pateinakis; Aikaterini Papagianni
Journal:  Int J Nephrol       Date:  2011-02-06

7.  Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease.

Authors:  Nicola C Edwards; William E Moody; Mengshi Yuan; Manvir K Hayer; Charles J Ferro; Jonathan N Townend; Richard P Steeds
Journal:  Am J Cardiol       Date:  2015-02-12       Impact factor: 2.778
  7 in total
  2 in total

1.  Myocardial Effective Transverse Relaxation Time T 2* is Elevated in Hypertrophic Cardiomyopathy: A 7.0 T Magnetic Resonance Imaging Study.

Authors:  Till Huelnhagen; Min-Chi Ku; Henning Matthias Reimann; Teresa Serradas Duarte; Andreas Pohlmann; Bert Flemming; Erdmann Seeliger; Christina Eichhorn; Victor A Ferrari; Marcel Prothmann; Jeanette Schulz-Menger; Thoralf Niendorf
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

2.  Vascular Senescence in Cardiovascular and Metabolic Diseases.

Authors:  Goro Katsuumi; Ippei Shimizu; Yohko Yoshida; Tohru Minamino
Journal:  Front Cardiovasc Med       Date:  2018-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.